Search

everythinglearnresearchcommunity

for

Search:↓

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

GFC is more effective than PRP for treating hair loss.

Higher FABP4 levels may help diagnose androgenetic alopecia early.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

The growth factor cocktail with FGF9 significantly increased hair density and diameter in patients with androgenetic alopecia.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

Autologous growth factor concentrate therapy shows promise for treating early-stage hair loss safely and effectively.

GFC improves hair quickly, while PRP offers longer-lasting benefits; using both sequentially is recommended.

The FG score is better at detecting hyperandrogenism in PCOS patients than testosterone levels or FAI, but testosterone is the recommended test for diagnosis.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

The FFA-QLI is a reliable tool for assessing quality of life in women with severe Frontal Fibrosing Alopecia.

Early diagnosis and treatment of frontal fibrosing alopecia are crucial to prevent permanent hair loss.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

Frontal Fibrosing Alopecia in men is often missed and can come with symptoms like facial bumps and hair loss on eyebrows and limbs.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Frontal fibrosing alopecia can be diagnosed by examining facial areas and treated with specific medications to stop its progression.

Current guidelines may overlook beard and sideburn involvement in diagnosing frontal fibrosing alopecia in men.

A 46-year-old man was diagnosed with frontal fibrosing alopecia, a condition usually seen in postmenopausal women.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

FGF signaling is crucial for starting feather development in chicken embryos.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Frontal fibrosing alopecia may be caused by an autoimmune reaction and hormonal imbalance.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

FFA in young women is often missed, and no single treatment works best.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.